- Home
- TNXP vs MGLD Comparison
TNXP vs MGLD Comparison
Compare TNXP & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- MGLD
- Stock Information
- Founded
- TNXP 2007
- MGLD 1996
- Country
- TNXP United States
- MGLD United States
- Employees
- TNXP N/A
- MGLD N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- TNXP Health Care
- MGLD Finance
- Exchange
- TNXP Nasdaq
- MGLD Nasdaq
- Market Cap
- TNXP 71.6M
- MGLD 64.6M
- IPO Year
- TNXP N/A
- MGLD N/A
- Fundamental
- Price
- TNXP $0.38
- MGLD $1.03
- Analyst Decision
- TNXP Strong Buy
- MGLD
- Analyst Count
- TNXP 2
- MGLD 0
- Target Price
- TNXP $53.50
- MGLD N/A
- AVG Volume (30 Days)
- TNXP 102.7M
- MGLD 48.3K
- Earning Date
- TNXP 11-12-2024
- MGLD 02-12-2025
- Dividend Yield
- TNXP N/A
- MGLD N/A
- EPS Growth
- TNXP N/A
- MGLD N/A
- EPS
- TNXP N/A
- MGLD N/A
- Revenue
- TNXP $11,291,000.00
- MGLD $32,511,000.00
- Revenue This Year
- TNXP $64.71
- MGLD N/A
- Revenue Next Year
- TNXP $24.49
- MGLD N/A
- P/E Ratio
- TNXP N/A
- MGLD N/A
- Revenue Growth
- TNXP 183.05
- MGLD N/A
- 52 Week Low
- TNXP $0.12
- MGLD $0.78
- 52 Week High
- TNXP $12.48
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- TNXP 55.72
- MGLD 29.62
- Support Level
- TNXP $0.37
- MGLD $1.02
- Resistance Level
- TNXP $0.58
- MGLD $1.77
- Average True Range (ATR)
- TNXP 0.07
- MGLD 0.15
- MACD
- TNXP 0.01
- MGLD -0.10
- Stochastic Oscillator
- TNXP 43.06
- MGLD 1.03
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.